Kaplan C C - OmicsDI

Show results for

Unknown (9442)
Transcriptomics (156)
Proteomics (92)
Genomics (42)
Metabolomics (4)
Other (2)
Genomic (1)
Methylation profiling (1)

Organisms

Homo sapiens (186)
Mus musculus (42)
Saccharomyces cerevisiae (12)
Oryctolagus cuniculus (5)
Rattus norvegicus (5)
Drosophila melanogaster (4)
Babesia microti (1)
Zaire ebolavirus (1)
Tai Forest ebolavirus (1)
Tetrahymena thermophila (1)
Ambystoma mexicanum (1)
Xenopus laevis (1)
Zea mays (1)
Rattus rattus (1)
Salmo salar (1)
Caenorhabditis elegans (1)
Gryllus bimaculatus (1)
Anopheles gambiae (1)
Bacteroides thetaiotaomicron (1)
Brassica napus (1)
Cytomegalovirus sp. (1)
Escherichia coli (1)
Glycine max (1)
Gossypium hirsutum (1)
Pseudomonas putida (1)
Rhodotorula toruloides (1)
Shewanella oneidensis MR-1 (1)

Organisms

Homo sapiens (9)
Mus musculus (3)
Gryllus bimaculatus (1)

Repository

biostudies-arrayexpress (175)
pride (69)
EGA (17)
ENA (16)
geo (9)
MassIVE (5)
MetaboLights (4)
jPOST (2)
dbGaP (1)
PanoramaPublic (1)

Tissue

Cell culture (19)
Epithelial cell (16)
Fibroblast (9)
Blood serum (5)
Brain (4)
Lung (4)
Blood (3)
Blood plasma (3)
Liver (3)
Retina (3)
Macrophage (2)
Neutrophil (2)
T cell (2)
Acute lymphoblastic leukemia cell line (1)
Adipose tissue (1)
Amniotic fluid (1)
Anal canal (1)
Blood cell (1)
Bone marrow (1)
Breast cancer cell (1)
Cerebrospinal fluid (1)
Colon (1)
Extracellular vesicle (1)
Fat cell (1)
Glioblastoma cell (1)
Heart (1)
HiPSC cell (1)
Kidney (1)
Leukocyte (1)
Melanocyte (1)

Disease

Breast cancer (6)
Glioblastoma (2)
Leber congenital amaurosis (2)
Lung cancer (2)
Malignant neoplasm of ovary (2)
Systemic lupus erythematosus (2)
Healthy (1)
Acute lymphoblastic leukemia (1)
Hypopituitary (1)
Normal (1)
Amyotrophic lateral sclerosis (1)
Anal canal squamous cell carcinoma (1)
Brain glioblastoma multiforme (1)
Colon cancer (1)
Emphysema (1)
Head and neck squamous cell carcinoma (1)
Hepatocellular carcinoma (1)
Human cytomegalovirus infection (1)
Insulin insensitivity (1)
Kidney cancer (1)
Non-small cell lung carcinoma (1)
Pancreatic ductal adenocarcinoma (1)
Pulmonary hypertension (1)
Skin melanoma (1)
Triple-receptor negative breast cancer (1)
Type 2 diabetes mellitus (1)

Technology Type

Mass Spectrometry (69)
Shotgun proteomics (38)
Bottom-up proteomics (9)
Gel-based experiment (8)
Affinity purification coupled with mass spectrometry proteomics (6)
Data-dependent acquisition (5)
All-ion fragmentation (3)
Top-down proteomics (3)
Mass spectrometry assay (2)
SWATH MS (2)
AB SOLiD 4 System, Illumina HiSeq 2500, Illumina HiSeq 2000, AB SOLiD System 3.0 (1)
Illumina HiSeq 2000 (1)
Mass spectrometry (1)
NMR spectroscopy (1)
Chemical cross-linking coupled with mass spectrometry proteomics (1)
Mass spectrometry imaging (1)
SRM/MRM (1)

Instrument Platform

Bio-Rad T100 Thermocycler (2)
Illumina HiSeq 2500 (2)
NextSeq 500 (2)
Q Exactive (2)
Dell Precision Tower 7910 workstation (1)
Affymetrix GCS3000 7G SCANNER (1)
GeneChip Hybridization Oveer 640 (1)
HIVE computer cluster (1)
IScan Illumina (1)
MinION (1)
Orbitrap Fusion Lumos (1)
Q Exactive Plus (1)
Xevo G2-S QTof (1)
Gas Chromatography MS - positive - low polarity - GC-MS (1)
Liquid Chromatography MS - positive - direct infusion (1)
Liquid Chromatography MS - positive - reverse phase (1)
Nuclear Magnetic Resonance (NMR) - (1)
LTQ Orbitrap Velos (1)

Publication Date

2013 (30)
2012 (26)
2015 (24)
2011 (22)
2014 (19)
2010 (18)
2023 (16)
2018 (16)
2021 (15)
2024 (12)
2022 (9)
2016 (9)
2026 (8)
2025 (8)
2020 (7)
2008 (7)
2019 (7)
2017 (4)
2009 (4)
2007 (3)
2006 (1)

CHEBI ID

CHEBI:15428 (2)
CHEBI:16000 (2)
CHEBI:16010 (2)
CHEBI:16027 (2)
CHEBI:16335 (2)
CHEBI:16704 (2)
CHEBI:18012 (2)
CHEBI:25017 (2)
CHEBI:78320 (2)
CHEBI:10642 (1)
CHEBI:1148 (1)
CHEBI:136236 (1)
CHEBI:136239 (1)
CHEBI:136245 (1)
CHEBI:140361 (1)
CHEBI:140362 (1)
CHEBI:14314 (1)
CHEBI:14336 (1)
CHEBI:15354 (1)
CHEBI:15355 (1)
CHEBI:15356 (1)
CHEBI:15366 (1)
CHEBI:15422 (1)
CHEBI:15611 (1)
CHEBI:15741 (1)
CHEBI:15756 (1)
CHEBI:15846 (1)
CHEBI:15891 (1)
CHEBI:15963 (1)
CHEBI:15996 (1)

Metabolite Name

2-Hydroxybutyrate (1)
2-Hydroxyglutarate (1)
2-hydroxypyridine (1)
2-oxoglutaric acid (1)
2-phospho-D-glyceric acid (1)
3-Hydroxybutyrate (1)
3-hydroxypyridine (1)
4-Aminobutyrate (1)
6-D-phosphogluconic acid (1)
ADP (1)
AMP (1)
ATP (1)
Acetate (1)
Adenosine (1)
Alanine (1)
Ascorbate (1)
Asparagine (1)
Aspartate (1)
Betaine (1)
Butyrate (1)
Carnitine (1)
Choline (1)
Citrate (1)
Creatine (1)
Creatine phosphate (1)
Creatinine (1)
Cystathionine (1)
Cysteine (1)
D-(+)-mannose (1)
D-fructose 6-phosphate (1)

First Public Date

2026 (4)
2023 (4)
2014 (3)
2025 (2)
2024 (2)
2022 (1)

Study type

Transcription profiling by array (110)
Proteomic profiling by array (16)
ChIP-seq (9)
RNA-seq of coding RNA (9)
ChIP-chip by tiling array (7)
Genotyping by array (5)
Comparative genomic hybridization by array (5)
Methylation profiling by array (5)
Unknown experiment type (2)
MicroRNA profiling by array (2)
Genotyping by high throughput sequencing (2)
ChIP-chip by array (1)
Transcription profiling by RT-PCR (1)

Release Date

2022 (1430)
2025 (1365)
2021 (1143)
2023 (1130)
2024 (1020)
2020 (804)
2019 (519)
2018 (390)
2017 (320)
2016 (271)
2015 (249)
2014 (190)
2026 (189)
2013 (141)
2012 (126)
2011 (99)
2010 (73)
2009 (54)
2008 (34)
2007 (18)
2006 (14)
2004 (8)
2005 (7)
2003 (4)
2002 (4)
2001 (4)
2000 (4)
1999 (3)
1998 (3)
1996 (1)

Lab affiliation

Weizmann Institute of Science (6)
Research Group Mitochondrial Disorders, Institute of Human Genetics, Technische Universität München, München, Germany (5)
Charles Perkins Centre, School of Life and Environmental Sciences and Sydney Medical School, University of Sydney, Camperdown, NSW, Australia (2)
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center (2)
Institute of Lung Biology and Disease and Comprehensive Pneumology Center, Helmholtz Zentrum München, Member of the German Center for Lung Research (DZL), Munich, German (2)
Proteomic Plateform Necker - SFR Necker - US24 (2)
1 Garvan Institute of Medical Research and The Kinghorn Cancer Centre, 384 Victoria Street Darlinghurst Sydney, NSW, 2010, Australia. 2 St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, Australia. (1)
Associate Professor Faculty of Biology Technion-Israel Institute of Technology, Technion City, Haifa 3200003, Israel (1)
Associate Professor, Department of biotechnology and research, Sir Ganga ram hospital, New Delhi -110060, Delhi, India (1)
Biomedical Engineering, Tufts University, Medford, MA (1)
CHU Angers, Angers, France Inserm UMR 1307, CNRS UMR 6075, Université de Nantes, CRCI2NA, Université d'Angers, Angers, France (1)
Cancer Stem Cell and Translation Medicine Lab, Innovative Cancer Drug Research and Development Engineering Center of Liaoning Province, Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, 110004, China (1)
Center Leader Proteomics Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS) Technical University Munich (TUM) Gregor-Mendel-Straße 4 85354 Freising GERMANY (1)
Centre de recherche du Centre Hospitalier Universitaire (CHU) de Quebec-Université Laval, Québec, QC, Canada Centre de recherche sur le cancer de l’Université Laval, Québec, QC, Canada PROTEO-Quebec Network for Research on Protein Function, Engineering, and Applications, Québec, QC, Canada Department of Molecular Biology, Medical Biochemistry and Pathology, Université Laval, Québec, QC, Canada (1)
Chief, Molecular Parasitology and Entomology Unit Laboratory of Malaria and Vector Research National Institutes of Health (1)
Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, United States (1)
Department of Biochemistry, Albert Einstein College of Medicine, The Bronx, NY 10461, United States (1)
Department of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, ON, N6A 5C1, Canada (1)
Department of Biochemistry, University of Colorado, Boulder, CO 80303, USA (1)
Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (1)
Department of Molecular Microbiology, Washington University School of Medicine in St. Louis; St. Louis, Missouri, United States of America. (1)
Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada (1)
Department of Surgery Hollings Cancer Center (HO 512H) Medical University of South Carolina (1)
Department of Traumatology and Acute Critical Medicine Osaka University Graduate School of Medicine (1)
Département de Neurochirurgie, CHU Angers, Angers, France Inserm UMR 1307, CNRS UMR 6075, Université de Nantes, CRCI2NA, Université d'Angers, Angers, France (1)
Environmental Toxicology Graduate Program and Department of Chemistry, University of California, Riverside, California 92521, United States (1)
Functional Cellular Networks Section Laboratory of Immune System Biology National Institute of Allergy and Infectious Diseases National Institutes of Health (1)
Head, Department of Biotechnology, University of Kashmir (1)
Helmholtz Zentrum München German Research Center for Environmental Health Institute of Diabetes Research Group Immune Tolerance in Diabetes Heidemannstraße 1 80939 München (1)
Hormones & Cancer Group, Kolling Institute, University of Sydney, Sydney 2065, Australia (1)

Tags

xref:PubMed:19373655 (1)
xref:PubMed:40740769 (1)
xref:PubMed:17108109 (1)
xref:PubMed:26826202 (1)
xref:PubMed:38827743 (1)
xref:PubMed:22561152 (1)

Previous page
1 / 975
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 975
Next page

Sort by:

Relevance

Page size

Hepatitis C Antiviral Long-term Treatment Against Cirrhosis (HALT-C)

Reprinted from http://www.haltctrial.org/

Purpose

The Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) Trial is a randomized controlled trial designed to evaluate the safety and efficacy of long-term use of pegylated inte...

phs000430.v1.p1 | EGA

A Myc transcriptional program that is independent of EMT drives a poor prognosis tumor-propagating phenotype in HER2+ breast cancer

The HER2 (ERBB2) and MYC genes are commonly amplified genes in breast cancer, yet little is known about their molecular and clinical interaction. Using a novel chimeric mammary transgenic approach and in vitro models, we demonstrate markedly increased self renewal and tumour propagating capability o...

ORGANISM(S): Homo sapiens

2013-09-24 | E-GEOD-43730 | biostudies-arrayexpress

Cutaneous nonpeptidergic neurons sense extracellular ATP to augment barrier repair and C. albicans host defense

PRJNA1458817 | ENA

Tenascin-C shapes TRAIL control over tumor immunity

TRAIL cytotoxicity is exploited as anti-cancer therapy since many years, however incomplete knowledge is generating many obstacles. Here, we address whether the highly abundant extracellular matrix molecule tenascin-C (TNC) orchestrating an immune suppressive tumor microenvironment and binding TRAIL...

ORGANISM(S): Mus musculus (Mouse)

2026-04-15 | PXD045388 | Pride

FACT and Spt6 Prevent Cryptic Transcription by Impeding H2A.Z Loading in Gene Bodies

H2A.Z is a highly conserved histone variant involved in several key nuclear processes. It is incorporated into promoters by SWR-C-related chromatin remodeling complexes, but whether it is also actively excluded from non-promoter regions is not clear. Here, we provide genomic and biochemical evidence...

ORGANISM(S): Saccharomyces cerevisiae

2015-05-12 | E-GEOD-62880 | biostudies-arrayexpress

Novel TSHB variant (c.217A>C) causing severe central hypothyroidism and pituitary hyperplasia.

Not available

S-EPMC9422232 | biostudies-literature

Immunopathogenesis of Hepatitis C Virus Infection.

Not available

S-EPMC4660249 | biostudies-literature

Bias-adjusted Kaplan-Meier survival curves for marginal treatment effect in observational studies.

Not available

S-EPMC6684083 | biostudies-literature

Prognostic significance of TG/HDL-C and non-HDL-C/HDL-C ratios in patients with non-small cell lung cancer: a retrospective study.